Department of Translational Neuroscience
Scientists at Barrow Neurological Institute are focused on research that improves the lives of patients with neurologic diseases. Barrow scientists work to discover the underlying mechanisms of diseases of the central nervous system, and work directly with our clinical colleagues to both advance our basic understanding of neurological diseases and translate these findings to the clinic, where they directly impact patient care.
Barrow scientists and physician-scientists within the Department of Translational Neuroscience are world leaders in neurodegenerative disease research, including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and Parkinson’s disease, as well as neuroimaging, traumatic brain injury, cerebrovascular diseases and stroke. They incorporate new and cutting edge technologies to explore disease pathogenesis as well as develop and test new therapies. Scientists in the Ivy Brain Tumor Center explore the mechanisms of brain tumor development and metastases, accelerate precision medicine approaches in neuro-oncology, and contribute to the largest Phase 0 clinical trials program in the world.
Barrow is a leading institution for the development and testing of medical devices that ultimately impact neurosurgery and neurology. The Barrow Neuroimaging Innovation Center develops novel brain and spinal cord imaging techniques that create new strategies to detect and monitor neurological diseases. The Barrow Innovation Center is a unique program directed by Neurosurgery Residents that work with faculty and other trainees from Barrow and our neighboring institutions to develop new device technologies, spin out new biotech companies, and advance our core mission of innovative educational opportunities for our next generation of physician-scientists.
We have joint PhD training program with Arizona State University and offer many training opportunities for postdoctoral fellows, undergraduate students, and high school students. Our faculty are international leaders in their respective fields and, together with our trainees, actively collaborate with scientists located throughout the country and around the world.
Through our innovative and collaborative culture, we strive to better understand the biologic mechanisms underlying neurologic disorders, develop and translate improved treatments to our patients, create new surgical devices used worldwide, and train the next generation of neuroscientists and clinician-scientists.
I welcome you to further explore the research interests of our investigators, develop collaborative projects with our scientists and clinicians, and inquire about our many training programs and career opportunities.
Irakliy Abramov, PhD
Siddhi Desai, PhD
Chelsea Faber, PhD
Sai Shilpa Kommaraju, PhD
Laura Mahady, PhD
Tigran Margaryan, PhD
Kimberly Meyers, PhD
Jennifer Miguel, PhD
Sonam Patel, PhD
Sudarshan Ragunathan, PhD
Nicholas Sisco, PhD
Meet the Summer 2023 Undergraduate Interns
Barrow Receives Over $2.1M in DoD Grants for ALS Research
Scientists, Clinicians Brainstorm Future of C9orf72 ALS, FTD Research
Awards & Recognitions — May 2023
Barrow Neurodegeneration Scientist Earns High-Risk, High-Reward Grants
DoD Funds Barrow Neuroimaging Study of Peripheral Nerve Injury, Repair
Awards & Recognitions – November 2022
Remyelination: Barrow Neuroimaging Scientists Explore ‘Next Frontier’ of MS Treatment
Summer 2022 Interns Present Projects at Symposiums
Barrow Faculty Named to National ALS Strategic Planning Team
Meet the 2022 Summer Undergraduate Research Interns at Barrow
Imaging Research Aims to Unravel How Parkinson’s Alters Brain Networks
Awards & Recognitions – January 2022
R01 Grant Funds Research of Levodopa-Induced Dyskinesia in Parkinson’s
Barrow Study Suggests Important Drug Target for Glioblastoma
Barrow Study Suggests Immune Cells Contribute to Neurodegeneration
Undergraduate Research Interns Celebrate Completion of Program